Loading clinical trials...
Loading clinical trials...
Randomized Phase II Trial of Three-weekly Cisplatinum and Pemetrexed Versus Split-dose d1 and d8 Cisplatinum and Pemetrexed In Advanced and Inoperable Non-squamous Non-small-cell Lung Cancer (NSCLC)
Conditions
Interventions
Cisplatinum
Pemetrexed
Locations
1
Germany
University hospital essen
Essen, North Rhine-Westphalia, Germany
Start Date
November 1, 2012
Primary Completion Date
May 1, 2014
Completion Date
April 1, 2015
Last Updated
December 5, 2012
NCT07486219
NCT06305754
NCT05098132
NCT06731413
NCT04585750
NCT07217301
Lead Sponsor
Universität Duisburg-Essen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions